Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Ernexa Therapeutics(ERNA) the EBIT is -4.104 M (--%), Miss estimate;the EPS is -3.4 (--%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITMiss expectations
-0.00B--
-0.00B--
-0.00B--%
EPSMiss expectations
-3.4--
-3.3--
-0.1000--%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf